Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

1.

Impact of meningococcal C conjugate vaccination campaign in Emilia-Romagna, Italy.

Pascucci MG, Di Gregori V, Frasca G, Rucci P, Finarelli AC, Moschella L, Borrini BM, Cavrini F, Liguori G, Sambri V, Bonanni P, Fantini MP.

Hum Vaccin Immunother. 2013 Dec 30;10(3). [Epub ahead of print]

PMID:
24384537
[PubMed - as supplied by publisher]
2.

Impact on disease incidence of a routine universal and catch-up vaccination strategy against Neisseria meningitidis C in Tuscany, Italy.

Bechini A, Levi M, Boccalini S, Tiscione E, Balocchini E, Canessa C, Azzari C, Bonanni P.

Vaccine. 2012 Oct 5;30(45):6396-401. doi: 10.1016/j.vaccine.2012.08.019. Epub 2012 Aug 23.

PMID:
22921931
[PubMed - indexed for MEDLINE]
3.
4.

Present situation and new perspectives for vaccination against Neisseria meningitidis in Tuscany, Central Italy.

Bechini A, Levi M, Boccalini S, Tiscione E, Ceccherini V, Taddei C, Balocchini E, Bonanni P.

J Prev Med Hyg. 2012 Jun;53(2):61-7.

PMID:
23240162
[PubMed - indexed for MEDLINE]
5.

Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data.

Novak RT, Kambou JL, Diomandé FV, Tarbangdo TF, Ouédraogo-Traoré R, Sangaré L, Lingani C, Martin SW, Hatcher C, Mayer LW, Laforce FM, Avokey F, Djingarey MH, Messonnier NE, Tiendrébéogo SR, Clark TA.

Lancet Infect Dis. 2012 Oct;12(10):757-64. doi: 10.1016/S1473-3099(12)70168-8. Epub 2012 Jul 18.

PMID:
22818241
[PubMed - indexed for MEDLINE]
6.

Serogroup C meningococci in Italy in the era of conjugate menC vaccination.

Stefanelli P, Fazio C, Sofia T, Neri A, Mastrantonio P.

BMC Infect Dis. 2009 Aug 22;9:135. doi: 10.1186/1471-2334-9-135.

PMID:
19698137
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Immunity against Neisseria meningitidis serogroup C in the Dutch population before and after introduction of the meningococcal c conjugate vaccine.

de Voer RM, Mollema L, Schepp RM, de Greeff SC, van Gageldonk PG, de Melker HE, Sanders EA, Berbers GA, van der Klis FR.

PLoS One. 2010 Aug 13;5(8):e12144. doi: 10.1371/journal.pone.0012144.

PMID:
20730091
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Impact of vaccination during an epidemic of serogroup C meningococcal disease in Salvador, Brazil.

Cardoso CW, Pinto LL, Reis MG, Flannery B, Reis JN.

Vaccine. 2012 Aug 10;30(37):5541-6. doi: 10.1016/j.vaccine.2012.06.044. Epub 2012 Jun 27.

PMID:
22749604
[PubMed - indexed for MEDLINE]
Free Article
9.

[Evolution of meningococcal infection among infant population in the autonomous community of Valencia (1996-2000). Effectiveness of A+C meningococcal vaccination].

Goicoechea Sáez M, Fullana Montoro AM, Momparler Carrasco P, Redondo Gallego MJ, Brines Solanes J, Bueno Cañigral FJ.

Rev Esp Salud Publica. 2003 Jan-Feb;77(1):125-42. Spanish.

PMID:
12696392
[PubMed - indexed for MEDLINE]
10.

Effectiveness of a mass immunization campaign against serogroup C meningococcal disease in Quebec.

De Wals P, De Serres G, Niyonsenga T.

JAMA. 2001 Jan 10;285(2):177-81.

PMID:
11176810
[PubMed - indexed for MEDLINE]
11.

Epidemiological pattern of meningococcal disease in Valencia, Spain. Impact of a mass immunization campaign with meningococcal C polysaccharide vaccine.

Pereiró I, Díez-Domingo J, Morant A, Gimeno C, Lerma M, San-Martín M, González A; Group for the Study of Invasive Diseases.

Scand J Infect Dis. 2001;33(8):581-4.

PMID:
11525350
[PubMed - indexed for MEDLINE]
12.

Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United States.

Lingappa JR, Rosenstein N, Zell ER, Shutt KA, Schuchat A, Perkins BA; Active Bacterial Core surveillance (ABCs) team.

Vaccine. 2001 Aug 14;19(31):4566-75.

PMID:
11483285
[PubMed - indexed for MEDLINE]
13.

Meningococcal quadrivalent (serogroups A, C, W135 and Y) tetanus toxoid conjugate vaccine (Nimenrix™).

Croxtall JD, Dhillon S.

Drugs. 2012 Dec 24;72(18):2407-30. doi: 10.2165/11209580-000000000-00000. Review.

PMID:
23231026
[PubMed - indexed for MEDLINE]
14.

Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study.

Noronha CP, Struchiner CJ, Halloran ME.

Int J Epidemiol. 1995 Oct;24(5):1050-7.

PMID:
8557439
[PubMed - indexed for MEDLINE]
15.

Effectiveness of a mass immunization campaign using serogroup C meningococcal conjugate vaccine.

De Wals P, Deceuninck G, Boulianne N, De Serres G.

JAMA. 2004 Nov 24;292(20):2491-4.

PMID:
15562128
[PubMed - indexed for MEDLINE]
16.

Meningococcal serogroup C conjugate vaccination in England and Wales: coverage and initial impact of the campaign.

Trotter CL, Ramsay ME, Kaczmarski EB.

Commun Dis Public Health. 2002 Sep;5(3):220-5.

PMID:
12434692
[PubMed - indexed for MEDLINE]
17.

Immunogenicity and safety of a quadrivalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (MenACWY-TT) administered to adults aged 56 Years and older: results of an open-label, randomized, controlled trial.

Dbaibo G, El-Ayoubi N, Ghanem S, Hajar F, Bianco V, Miller JM, Mesaros N.

Drugs Aging. 2013 May;30(5):309-19. doi: 10.1007/s40266-013-0065-0.

PMID:
23494214
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Is a single dose of meningococcal serogroup C conjugate vaccine sufficient for protection? experience from the Netherlands.

Kaaijk P, van der Ende A, Berbers G, van den Dobbelsteen GP, Rots NY.

BMC Infect Dis. 2012 Feb 8;12:35. doi: 10.1186/1471-2334-12-35.

PMID:
22316426
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

[Invasive meningococcal disease in the Czech Republic - analysis of the epidemiological situation and vaccination strategy recommendations].

Křížová P, Vacková Z, Musílek M, Kozáková J.

Epidemiol Mikrobiol Imunol. 2013 Dec;62(4):138-47. Czech.

PMID:
24467175
[PubMed - in process]
20.

Meningococcal C vaccines: the Canadian experience.

De Wals P.

Pediatr Infect Dis J. 2004 Dec;23(12 Suppl):S280-4.

PMID:
15597070
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk